ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2019.0.227 2019.0.227 2020-09-302020-09-302019-10-01falseNo description of principal activity00truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09237601 2019-10-01 2020-09-30 09237601 2018-10-01 2019-09-30 09237601 2020-09-30 09237601 2019-09-30 09237601 c:Director1 2019-10-01 2020-09-30 09237601 d:MotorVehicles 2019-10-01 2020-09-30 09237601 d:MotorVehicles 2020-09-30 09237601 d:MotorVehicles 2019-09-30 09237601 d:MotorVehicles d:OwnedOrFreeholdAssets 2019-10-01 2020-09-30 09237601 d:OfficeEquipment 2019-10-01 2020-09-30 09237601 d:OfficeEquipment 2020-09-30 09237601 d:OfficeEquipment 2019-09-30 09237601 d:OfficeEquipment d:OwnedOrFreeholdAssets 2019-10-01 2020-09-30 09237601 d:OwnedOrFreeholdAssets 2019-10-01 2020-09-30 09237601 d:CurrentFinancialInstruments 2020-09-30 09237601 d:CurrentFinancialInstruments 2019-09-30 09237601 d:CurrentFinancialInstruments d:WithinOneYear 2020-09-30 09237601 d:CurrentFinancialInstruments d:WithinOneYear 2019-09-30 09237601 d:ShareCapital 2020-09-30 09237601 d:ShareCapital 2019-09-30 09237601 d:RetainedEarningsAccumulatedLosses 2020-09-30 09237601 d:RetainedEarningsAccumulatedLosses 2019-09-30 09237601 c:OrdinaryShareClass1 2019-10-01 2020-09-30 09237601 c:OrdinaryShareClass1 2020-09-30 09237601 c:OrdinaryShareClass1 2019-09-30 09237601 c:FRS102 2019-10-01 2020-09-30 09237601 c:AuditExempt-NoAccountantsReport 2019-10-01 2020-09-30 09237601 c:FullAccounts 2019-10-01 2020-09-30 09237601 c:PrivateLimitedCompanyLtd 2019-10-01 2020-09-30 09237601 2 2019-10-01 2020-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09237601









PRECISION SURGERY LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2020

 
PRECISION SURGERY LIMITED
REGISTERED NUMBER: 09237601

BALANCE SHEET
AS AT 30 SEPTEMBER 2020

2020
2019
Note
£
£

Fixed assets
  

Tangible assets
 4 
8,910
2,241

  
8,910
2,241

Current assets
  

Cash at bank and in hand
 5 
42,107
37,596

  
42,107
37,596

Creditors: amounts falling due within one year
 6 
(18,240)
(15,628)

Net current assets
  
 
 
23,867
 
 
21,968

Total assets less current liabilities
  
32,777
24,209

  

Net assets
  
32,777
24,209


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
32,677
24,109

  
32,777
24,209


Page 1

 
PRECISION SURGERY LIMITED
REGISTERED NUMBER: 09237601
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2020

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Dr Giampaolo Gini
Director

Date: 22 February 2021

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
PRECISION SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

1.


General information

Precision Surgery Limited, 09237601, is a private limited company limited by shares, incorporated in England and Wales, with its registered office and principal place of business at Belmont House, Shrewsbury Business Park, Shrewsbury, Shropshire, SY2 6LG. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Page 3

 
PRECISION SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

2.Accounting policies (continued)

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Motor vehicles
-
25% reducing balance
Office equipment
-
25% reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
PRECISION SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

2.Accounting policies (continued)

 
2.8

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Profit and loss account.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 
2.9

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 0 (2019 - 0).

Page 5

 
PRECISION SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

4.


Tangible fixed assets





Motor vehicles
Office equipment
Total

£
£
£



Cost or valuation


At 1 October 2019
6,999
80
7,079


Additions
11,855
-
11,855


Disposals
(6,999)
-
(6,999)



At 30 September 2020

11,855
80
11,935



Depreciation


At 1 October 2019
4,784
55
4,839


Charge for the year on owned assets
2,964
6
2,970


Disposals
(4,784)
-
(4,784)



At 30 September 2020

2,964
61
3,025



Net book value



At 30 September 2020
8,891
19
8,910



At 30 September 2019
2,215
25
2,240


5.


Cash and cash equivalents

2020
2019
£
£

Cash at bank and in hand
42,107
37,598

42,107
37,598


Page 6

 
PRECISION SURGERY LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2020

6.


Creditors: Amounts falling due within one year

2020
2019
£
£

Trade creditors
76
186

Other taxation and social security
6,400
2,069

Other creditors
10,810
12,623

Accruals and deferred income
954
750

18,240
15,628



7.


Share capital

2020
2019
£
£
Allotted, called up and fully paid



100 (2019 - 100) Orinary shares of £1.00 each
100
100

Page 7